#AutoinflammatoryAware

World Autoinflammatory Awareness Month September

[Chris Walker @DarthPyrin]

It is time for #HumpDayShenanigans Take 2 to raise #AutoinflammatoryDiseaseAwareness for #WorldAutoinflammatoryAwarenessMonth on behalf of @FMFandAID Come hang, #donate and #share the #gofundme link

https://t.co/jdwzwiwNpG https://t.co/I63wOy96UI https://t.co/4BqCHtu4Dl

[ASAS @Official_ASAS]

New ASAS-COMOSPA study: A
💊 Biologic therapies, especially monoclonal TNF-inhibitors, effectively treat uveitis.
👁️ Uveitis frequency decreased in SpA patients post-2000 with biologics introduction.

#Uveitis #SpA #COMOSPA

[Armen Yuri Gasparyan @ArmenYuri]

Obstetric and neonatal outcomes in pregnancies with familial mediterranean fever: a comparative study
@AAlliance_SAID @IndiaSAIDgenome @CdnANetwork @autoinflamaware @GencTRASD @hande_snc @anarsiknotrofil @Gulsandaluzun @ReumatologiaU
https://t.co/zzna0pTzaM

[#AutoinflammatoryAware @autoinflamaware]

.@FMFandAID have been interviewing patients & parents throughout World Autoinflammatory Awareness Month.

Want to hear more? Check out their YouTube Channel https://t.co/eQu0K937Oj

#AutoinflammatoyAware

[Rare Autoinflammatory Conditions Community - UK®️ @RACC_UK]

📣 Shining a spotlight on Jack Drda 📣

Research interest is immunometabolism, with an emphasis on hepatic cholesterol biosynthesis and isoprenoid metabolites in rare autoinflammatory disorders, such as MKD and the newly described PMVK
#research #immunometablism 💚 🩷 💙

[ERN ReCONNET 🇪🇺 @ern_reconnet]

Don’t miss TODAY’S @ERNReCONNET webinar at 16 CEST on “Microvascular Involvement in Antiphospholipid Syndrome (APS)” with Prof. Savino Sciascia, moderated by Prof. Ricard Cervera.
✍️Make sure you're registered to participate: https://t.co/nUBhDfThxu

[FMF & AID Global Association @FMFandAID]

Patient Interviews – Raising Awareness
This month we have scheduled several live patient interviews to raise awareness. We start tomorrow, Sept 3rd, with Josée, a patient and patient representative from Chile. https://t.co/eL3Hc46SYj

[#AutoinflammatoryAware @autoinflamaware]

📢 New! European Society of Cardiology

2025 Patient Guidelines for pericarditis & myocarditis are available!
Clear, accessible information to support patients & families.

📄 Download here: https://t.co/gQh8pttVVl

#esc2025 #PatientVoicesMatter #pericarditis #myocarditis
💚🩷💙

[FMF & AID Global Association @FMFandAID]

📢 September is Autoinflammatory Awareness Month – Navigating the Medical Maze
Most doctors still fail to recognize these rare diseases, because they can’t diagnose what they don’t know.
💛 Join us and help raise awareness: https://t.co/cEJTxAD932
#AutoinflammatoryAwarenessMonth

[Armen Yuri Gasparyan @ArmenYuri]

Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review
@AAlliance_SAID @CdnANetwork @autoinflamaware @CollegioCrei @ReumatologiaU @ComunidadSar
https://t.co/tp5gxhTESR

[#AutoinflammatoryAware @autoinflamaware]

@ArmenYuri @AAlliance_SAID @IndiaSAIDgenome @CdnANetwork Sharing with .@FMFandAID & .@RACC_UK 🫶🏼

Thank you!

[ClinRheumatol @ClinRheumatol]

A disproportionality analysis of FAERS data (2012–2022) reveals distinct safety profiles of #JAKinhibitors in #RheumatoidArthritis:
🔴 Baricitinib → Highest risk for CV events & cancer
🟠 Upadacitinib → ⬆️risk for respiratory & GI events
🟢 Tofacitinib → Lower cancer risk but more MSK AEs
📢 Personalized risk assessment is 🔑 for safe prescribing!
👉https://t.co/hYeeoe9lSV

[Alessia Alunno @alessia_alunno]

📣If you are a person living with a #rheumatic disease and haven’t had the chance to share your experience on #cardiovascular risk and prevention, the survey below from a @eular_org study group is still open and more languages are available. Many thanks for your contribution!

[FMF & AID Global Association @FMFandAID]

Autoinflammatory diseases are rare genetic conditions of the innate immune system, which cause debilitating and recurring symptoms.
#periodicfevers #autoinflammatorydiseases #RareDiseaseDay2025

[CRMO @Fight_CRMO]

Towards better management of sterile bone inflammation

Jürgen Braun

Nature Reviews Rheumatology (2025)

#CRMO

[Annals of the Rheumatic Diseases @eular_ARD]

🅰️🅰️ What do you think about bDMARDs in renal AA #amyloidosis?

84 patients👫
3️⃣ aetiological subgroups:
🔵 chronic inflammatory diseases + AA ⇒ #tocilizumab
🔴 autoinflammatory syndrome + AA⇒ #IL1inhibitors
🔘 idiopathic AA ⇒ #tocilizumab

🔗 https://t.co/IeydpUxnuD

[NatRevRheumatol @NatRevRheumatol]

Our #JanuaryIssue is out now! Featuring #Reviews on the ‘Treg paradox’ in #inflammatory #arthritis, classification of the #autoinflammatory interferonopathies and an update on #autoantibodies in the idiopathic inflammatory myopathies.

https://t.co/SDOLiblatm

[NatRevRheumatol @NatRevRheumatol]

#JanuaryIssue | Emerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus

The authors propose a pathogenesis-based classification of #autoinflammatory interferonopathies in this #Review

https://t.co/3iWdasHxN9

[The Journal of Rheumatology @jrheum]

Images in Rheumatology

Autoinflammatory Diseases and Vasculitis: The Missing Link

📰 https://t.co/Wk7DNGUpii

#familialmediterraneanfever #autoinflammatorydiseases #vasculitis

[Alexandru Stieber @AlexStibi]

The essentials on Blau syndrome, brought to you by #GRAI (Romanian Group for #Autoinflammatory Diseases).